Abstract
Case summary
Two 55-year-old male patients and a 52-year-old male patient with cyclic high fever were admitted to the department of internal medicine. Three of the patients were diagnosed with malaria caused by P. vivax based on a peripheral blood smear. The patients were treated with hydroxychloroquine and premaquine but complained of decreased visual acuity. The patients were examined with funduscopy, fluorescein angiography, and optical coherence tomography. The first case showed 2 areas of retinal hemorrhages on the macular in the right eye and 1 area of retinal hemorrhage in the left eye. The second case showed many cotton-wool spots along with a number of small retinal hemorrhages and tortuous blood vessels in both eyes. The third case showed 1 area of retinal hemorrhage in the right eye and many cotton-wool spots in both eyes.
Conclusions
P. vivax malaria rarely causes retinal hemorrhage. Manifestations of retinal hemorrhage and degree of visual acuity loss may vary among patients. P. vivax malaria should be considered when patients with unexplained high fever present with retinal hemorrhage, even without a history of overseas travel.
References
2. Biswas J, Fogla R, Srinivasan P, et al. Ocular malaria. A clinical and histopathologic study. Ophthalmology. 1996; 103:1471–5.
3. Beare NA, Taylor TE, Harding SP, et al. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg. 2006; 75:790–7.
4. Chai IH, Lim GI, Yoon SN, et al. Occurrence of tertian malaria in a male patient who has never been abroad. Korean J Parasitol. 1994; 32:195–200.
5. Cho SY, Kong Y, Park SM, et al. Two vivax malaria cases detected in Korea. Korean J Parasitol. 1994; 32:281–4.
6. Lee JS, Kho WG, Lee HW, et al. Current status of vivax malaria among civilians in Korea. Korean J Parasitol. 1998; 36:241–8.
7. Yi KJ, Chung MH, Kim HS, et al. A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy. Korean J Parasitol. 1998; 36:143–6.
8. Mackintosh CL, Beeson JG, Marsh K. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 2004; 20:597–603.
9. Looareesuwan S, Warrell DA, White NJ, et al. Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg. 1983; 32:911–5.
10. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005; 4:827–40.
11. Maude RJ, Dondorp AM, Abu Sayeed A, et al. The eye in cerebral malaria: what can it teach us? Trans R Soc Trop Med Hyg. 2009; 103:661–4.
12. Hidayat AA, Nalbandian RM, Sammons DW, et al. The diagnostic histopathologic features of ocular malaria. Ophthalmology. 1993; 100:1183–6.
13. Choi HJ, Lee SY, Yang H, Bang JK. Retinal haemorrhage in vivax malaria. Trans R Soc Trop Med Hyg. 2004; 98:387–9.
14. Oh J, Kim HS, Huh K. Cerebral malaria associated with retinal hemorrhage on macular area. J Korean Ophthalmol Soc. 2003; 44:2699–704.
15. Beare NA, Taylor TE, Harding SP, et al. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg. 2006; 75:790–7.
16. Beare NA, Southern C, Kayira K, et al. Visual outcomes in children in Malawi following retinopathy of severe malaria. Br J Ophthalmol. 2004; 88:321–4.
17. Nagpal KC, Goldberg MF, Rabb MF. Ocular manifestations of sickle hemoglobinopathies. Surv Ophthalmol. 1977; 21:391–411.
18. Choy YJ, Park JS. A Case of bilateral retinal hemorrhages caused by plasmodium vivax malaria. J Korean Ophthalmol Soc. 2010; 51:626–30.
19. Beare NA, Southern C, Chalira C, et al. Prognostic significance and course of retinopathy in children with severe malaria. Arch Ophthalmol. 2004; 122:1141–7.
Table 1.
Year | 1989 | 1989 | 1997 | 1998 | 2002 | 2006 | 2009 | 2010 | 2010 |
---|---|---|---|---|---|---|---|---|---|
Gender/age | M/18 | F/24 | M/24 | M/31 | M/22 | M/38 | M/52 | M/55 | M/55 |
Hemoglobin (g/dl) | NA* | 9.4 | 7.6 | 9.6 | 10.0 | 7.5 | 10.5 | 6.9 | 7.6 |
Platelet count (/μ l) | NA | Normal | 35,000 | 47,000 | 145,000 | 125,000 | 93,000 | 154,000 | 53,000 |
Parasitemia (/μ l) | NA | NA | >100,000 | 7,000 | 57,000 | NA | 9,188 | 1,701 | 2,070 |
Initial VA† | 20/80 | 20/80 | NA | NA | 20/800 | 20/100 | 20/100 | 20/40 | 20/20 |
Final VA | 20/40 | 20/30 | Recovered | Recovered | 20/800 | 20/100 | 20/32 | 20/40 | 20/20 |
Eye involved | One | Both | One | One | Both | Both | Both | Both | Both |
Timing of hemorrhage | Before therapy | NA | Before therapy | Before therapy | 1 day after therapy | 49 days after therapy | 6 days after therapy | 7 days before therapy | 1 month before therapy |
Fundoscopic finding | Preretinal hemorrhage | Subhyaloid hemorrhage | Preretinal hemorrhage | Retinal hemorrhage | Subhyaloid hemorrhage | Preretinal hemorrhage | Retinal hemorrhage Roth spot CWS‡ | Retinal hemorrhage Roth spot CWS Vascular tortousity | Retinal hemorrhage CWS |